Novel Alzheimer’s Pill May Slow Decline in Some High-Risk Patients

(MedPage Today) — A phase III trial of investigational valiltramiprosate (ALZ-801) did not meet its primary endpoint in people with early symptomatic Alzheimer’s disease, but the drug did show benefits in a prespecified population with mild cognitive…